Home > En > Phd defense of Charlotte DUCHEMIN (laboratoire SUBATECH) on 29th september (...)

Phd defense of Charlotte DUCHEMIN (laboratoire SUBATECH) on 29th september 2015

Thursday 10 September 2015

Abstract

Nuclear medicine is a specialty that uses radioactive nuclei for therapy or diagnosis of diseases such as different types of cancer. These radionuclides are coupled to carrier molecules to target sick cells. Currently, only few isotopes are used in clinical practice. However, many others may be of medical interest due to their emitted radiation and/or their half-life that can be adapted to the carrier molecule transit time and to the pathology. The aim of this PhD thesis is to study the production of innovative radionuclides for therapy and diagnosis applications in collaboration with the GIP ARRONAX, which possesses a multi-particle high energy cyclotron. A fundamental physical parameter to access the production rate of a radionuclide is the production cross section. Experimental data were measured for a selection of radionuclides: photon emitter (Tc-99m) and positron emitter (Sc-44g) for diagnosis, as well as electron emitters (Re-186, Tb-155 and Sn-117m) and α particles emitters (Th-226, Ra-223 and Bi-213) for therapeutic applications. These acquired data are obtained using alternative production routes compared to the commonly used. Data related to the contaminants produced during the irradiations were also extracted. The experimental cross section values are compared with theoretical model predictions. The large set of data obtained contributes to the theoretical physicist studies allowing to constrain their models to improve and/or validate them.